Checkpoint Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2017

Stockholders' Equity Note [Abstract]

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes restricted stock award activity for the six months ended June 30, 2017.

			Weighted Average
			Grant Date Fair
	Number of Units		Value
Nonvested at December 31, 2016		2,533,063	$	2.93
Granted		110,000		5.43
Vested		(140,625)		0.07
Nonvested at June 30, 2017		2,502,438	$	3.20

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes stock option award activity for the six months ended June 30, 2017:

					Weighted Average
					Remaining
			Weighted Average		Contractual Life
	Stock Options		Exercise Price		(in years)
Outstanding as of December 31, 2016		60,000	$	5.43		9.96
Granted		-		-
Outstanding as of June 30, 2017		60,000	$	5.43		9.59

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of warrant activities for the six months ended June 30, 2017 is presented below:

					Weighted Average
					Remaining
			Weighted Average		Contractual Life
	Warrants		Exercise Price		(in years)
Outstanding as of December 31, 2016		4,331,106	$	6.62		4.67
Granted		-		-
Outstanding as of June 30, 2017		4,331,106	$	6.62		4.17

Schedule of Share-based Compensation, Activity [Table Text Block]

The following table summarizes stock-based compensation expense for the three and six months ended June 30, 2017 and 2016 (in thousands).

	For the three months ended June 30,				For the six months ended June 30,
	2017		2016		2017		2016
Research and development	$	1,946	$	457	$	2,352	$	1,225
General and administrative		436		346		1,009		666
Total stock-based compensation expense	$	2,382	$	803	$	3,361	$	1,891

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details